首页> 外文期刊>Bone marrow transplantation >Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
【24h】

Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.

机译:巨细胞病毒是骨髓移植后极晚的间质性肺炎的病因。

获取原文
获取原文并翻译 | 示例
       

摘要

Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality after allogeneic transplant. Interstitial pneumonia (IP) is the most common manifestation of CMV in BMT patients, with a 30-48% mortality rate despite adequate treatment. Most CMV infection occurs in the first 100 days. However, prolonged ganciclovir (GCV) prophylaxis has favored the occurrence of late CMV IP, probably by inhibition of the development of CMV-specific T cell lymphocyte responses. We report the case of a patient treated with an allogeneic BMT who received pre-emptive GCV until day +100 because of CMV-positive antigenemia. He developed a CMV IP on day +811 post BMT, which responded to treatment. We intend to alert clinicians that even at long-term (>1 year) post-BMT, CMV is a possible cause of IP in high-risk patients.
机译:巨细胞病毒(CMV)感染是异基因移植后发病和死亡的重要原因。间质性肺炎(IP)是BMT患者最常见的CMV表现,尽管进行了适当的治疗,其死亡率仍为30-48%。大多数CMV感染发生在前100天。但是,更长时间的更昔洛韦(GCV)预防已经支持了晚期CMV IP的发生,可能是通过抑制CMV特异性T细胞淋巴细胞应答的发展来实现的。我们报道了一名接受异体BMT治疗的患者,该患者由于CMV阳性抗原血症而先发制人的GCV直至+100天。他在BMT后+811天开发了CMV IP,对治疗有反应。我们打算提醒临床医生,即使在BMT后长期(> 1年),CMV仍可能是高危患者IP的病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号